Claude B. Sirlin
University of California San Diego
2 papers in the Anchorcite directory, published between 2017 and 2018, cited 8,750 times in total.
ORCID profileResearch topics
- Hepatocellular Carcinoma Treatment and Prognosis · 2 papers
- Head and Neck Cancer Studies · 2 papers
- Hepatitis B Virus Studies · 1 paper
- Colorectal Cancer Treatments and Studies · 1 paper
Frequent co-authors
- Jorge A. Marrero · 2 papers
- Laura Kulik · 2 papers
- Andrew Xiuxuan Zhu · 2 papers
- Richard S. Finn · 2 papers
- Michael M. Abecassis · 2 papers
- Lewis Rowland Roberts · 2 papers
- Julie K. Heimbach · 2 papers
- Mohammad Hassan Murad · 1 paper
Papers
- Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver DiseasesHepatology · 2018 · 4,629 citations
Purpose and ScopeThis guidance provides a data-supported approach to the diagnosis, staging, and treatment of patients diagnosed with hepatocellular carcinoma (HCC).A guidance document is different from a guideline.Guidelines are developed by a multidisciplinary panel of experts who rate the quality…
- AASLD guidelines for the treatment of hepatocellular carcinomaHepatology · 2017 · 4,121 citations
Potential conflict of interest: Laura M. Kulik is on the advisory board for Gilead, Bayer, Eisai, Salix, and Bristol‐Myers Squibb. Richard Finn consults for Pfizer, Bayer, Novartis, Merck, and Bristol‐Myers Squibb. Claude B. Sirlin consults for and has received grants…
Metadata from OpenAlex (CC0).